Siyakhana: Community Health Worker Training to Reduce Depression and Substance Use Stigma in TB/HIV Care in South Africa

Sponsor
University of Maryland, College Park (Other)
Overall Status
Recruiting
CT.gov ID
NCT05282173
Collaborator
Medical Research Council, South Africa (Other), National Institute of Mental Health (NIMH) (NIH)
60
1
2
13.8
4.4

Study Details

Study Description

Brief Summary

Poor engagement in care contributes to HIV- and TB-related morbidity and mortality in South Africa (SA). Community health workers (CHWs) are frontline lay health workers who work to re-engage patients who are lost to follow-up (LTFU) in HIV/TB care. Patients with depression and substance use (SU) have a greater likelihood of being LTFU in HIV/TB care, and there is evidence that CHWs may exhibit stigma towards these patients. When CHWs have negative attitudes towards these patients, on average they spend less time with these patients, are less likely to implement evidence-based practices, and deliver less patient-centered care. Therefore, this purpose of this study is to examine the implementation and preliminary effectiveness of a brief training ("Siyakhana"). The purpose of this training is to provide CHWs with psychoeducation, skills, and support around working with HIV/TB patients with depression/SU. The investigators will assess the training's implementation and changes in CHWs' stigma towards HIV/TB patients with depression/SU.

Detailed Description

South Africa (SA) has the highest number of people living with HIV in the world and a high tuberculosis (TB) burden. Poor engagement in care contributes to HIV- and TB-related morbidity and mortality. In this context, community health workers (CHWs) are frontline lay health workers who play a central role in re-engaging patients who are lost to follow-up (LTFU) in HIV/TB care. Even with existing CHW programs focused on re-engaging patients who are LTFU, people with depression, hazardous alcohol use, or other substance use (SU) are particularly susceptible to poor engagement in HIV/TB care and have a greater likelihood of being LTFU. At the moment, CHWs receive minimal, if any, training on depression and SU, and there is some evidence that CHWs may exhibit stigma towards these patients. When CHWs have negative attitudes towards these patients, on average they spend less time with these patients, are less likely to implement evidence-based practices, and deliver less patient-centered care. Therefore, the purpose of this study is to examine the implementation and preliminary effectiveness of a brief training ("Siyakhana") focused on providing CHWs with psychoeducation, skills, and support around working with patients with depression/SU. In a Type 2, hybrid effectiveness-implementation trial, and using a stepped wedge design, the investigators will primarily assess the training's implementation (feasibility, acceptability, and fidelity) and changes in CHWs' stigma towards HIV/TB patients with depression/SU.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
This study uses a stepped-wedge design. All groups of CHWs receive both treatment as usual (TAU) and the stigma reduction training ("Siyakhana"). Randomization will dictate the timing/order in which each group receives the Siyakhana training.This study uses a stepped-wedge design. All groups of CHWs receive both treatment as usual (TAU) and the stigma reduction training ("Siyakhana"). Randomization will dictate the timing/order in which each group receives the Siyakhana training.
Masking:
None (Open Label)
Masking Description:
The staff member who conducts role-play assessments with participants will be minimally involved in the Siyakhana training.
Primary Purpose:
Health Services Research
Official Title:
Training CHWs to Support Re-Engagement in TB/HIV Care in the Context of Depression and Substance Use
Actual Study Start Date :
Jun 8, 2022
Anticipated Primary Completion Date :
Jul 1, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Treatment As Usual (TAU)

Monitoring of treatment as usual (i.e., routine interactions between community health workers (CHWs) and their patients).

Experimental: Siyakhana CHW Training

The Siyakhana CHW Training is a multi-day group training that aims to reduce stigma around mental health and substance use among CHWs. It integrates psychoeducation around TB/HIV, stigma, depression, and substance use, including countering myths and stereotypes around mental health and substance use; skills for CHW self-care; evidence-based skills for working with patients living with depression and substance use, such as components of motivational interviewing and problem-solving therapy; and exposure to individuals with lived experience of mental health and substance use. The training is a combination of informative presentations, discussions, worksheets/activities, and role-plays aimed at increasing awareness of mental health and substance use, reducing stigma, and improving interactions when working with patients with HIV/TB and mental health and substance use concerns.

Behavioral: Siyakhana CHW Training
Please see arm description.
Other Names:
  • Siyakhana
  • Siyakhana - C
  • Outcome Measures

    Primary Outcome Measures

    1. CHW stigma towards depression and substance use [Change between baseline assessment and 3-month follow-up (approximately 3-months post-training)]

      CHW stigma towards depression measured using the Social Distance Scale (SDS). SDS scores range from 6 to 24, with higher scores indicating more desired social distance (more stigma).

    2. Training Feasibility [3-months post-training]

      The percentage of training sessions attended across all CHWs. The training will be considered feasible if over 75% of sessions are attended.

    3. Acceptability [3-months post-training]

      Acceptability subscale of the John Hopkins D&I Measure, a 12-item measure for assessing dissemination and implementation outcomes in low- and middle-income settings. This measure will specifically assess CHW's perceived satisfaction, relevance, usefulness, comprehension, and comfort level of the training. Items are rated on a 0-3 scale, and averaged, with lower scores (closer to 0) indicating low acceptability and higher scores (closer to 3) indicating higher acceptability.

    4. CHW Training Fidelity [3-months post-training]

      20% of CHW role-plays at the 3-month follow-up assessment (approximately 3-months post-training) will be rated using a fidelity assessment based on training components. A fidelity score will be calculated for each rated role-play based on the proportion of training components delivered as intended during role-plays. A final fidelity score, made up of the average of individual fidelity scores, will then be calculated.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • At least 18 years old

    • Employed as a CHW through a partner non-governmental organization (NGO) that provides HIV/TB CHW services

    • Works with patients who have HIV and TB, some of whom may be struggling with depression or substance use

    Exclusion Criteria:
    • Unable to complete informed consent or study procedures in English or Xhosa

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 South African Medical Research Council Cape Town Western Cape South Africa

    Sponsors and Collaborators

    • University of Maryland, College Park
    • Medical Research Council, South Africa
    • National Institute of Mental Health (NIMH)

    Investigators

    • Principal Investigator: Jessica F Magidson, PhD, University of Maryland
    • Principal Investigator: Bronwyn J Myers, PhD, Medical Research Council, South Africa

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Maryland, College Park
    ClinicalTrials.gov Identifier:
    NCT05282173
    Other Study ID Numbers:
    • EC039-10/2021
    • R34MH122268
    First Posted:
    Mar 16, 2022
    Last Update Posted:
    Jul 7, 2022
    Last Verified:
    Jul 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University of Maryland, College Park
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 7, 2022